BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30857958)

  • 21. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientists recall progress and promise of translational research.
    Marwick C
    J Natl Cancer Inst; 2001 Jan; 93(1):13-5. PubMed ID: 11136835
    [No Abstract]   [Full Text] [Related]  

  • 23. Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab.
    de Lima Lopes G; Gluck S
    J Clin Oncol; 2007 Aug; 25(22):3382-3; author reply 3383. PubMed ID: 17664490
    [No Abstract]   [Full Text] [Related]  

  • 24. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision medicine in oncology.
    Takebe N; Yap TA
    Curr Probl Cancer; 2017; 41(3):163-165. PubMed ID: 28372822
    [No Abstract]   [Full Text] [Related]  

  • 26. [Latest diagnostic methods in fields outside of otorhinolaryngology: current status and overview of individualized therapy using companion diagnostic drugs and molecular targeting drugs for the management of breast cancer].
    Hashimoto J; Tamura K; Fujiwra Y
    Nihon Jibiinkoka Gakkai Kaiho; 2014 Mar; 117(3):161-7. PubMed ID: 24834544
    [No Abstract]   [Full Text] [Related]  

  • 27. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials.
    LoRusso PM; Freidlin B
    J Natl Cancer Inst; 2023 Feb; 115(2):122-124. PubMed ID: 36448688
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 31. Precision medicine strategies in oncology: mixed approaches to matched therapies.
    Borcoman E; Le Tourneau C
    Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361
    [No Abstract]   [Full Text] [Related]  

  • 32. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mind the Gap: Precision Oncology and Its Potential to Widen Disparities.
    Huey RW; Hawk E; Offodile AC
    J Oncol Pract; 2019 Jun; 15(6):301-304. PubMed ID: 31112478
    [No Abstract]   [Full Text] [Related]  

  • 34. Personalised cancer management: closer, but not here yet.
    Piccart M
    Ann Oncol; 2013 Aug; 24(8):1951-5. PubMed ID: 23878113
    [No Abstract]   [Full Text] [Related]  

  • 35. The future of oncology therapeutics.
    Mansinho A; Boni V; de Miguel M; Calvo E
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
    [No Abstract]   [Full Text] [Related]  

  • 36. The FDA Oncology Center of Excellence and precision medicine.
    Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
    Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trastuzumab beyond progression in advanced breast cancer: national guidance versus oncologist's decision.
    Wong HH; Collins J; McAdam K; Wilson C
    Oncology; 2014; 86(1):22-3. PubMed ID: 24335099
    [No Abstract]   [Full Text] [Related]  

  • 38. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The large print giveth and the small print taketh away: preemptive treatment of serologically active, clinically quiet systemic lupus erythematosus.
    Liang MH; Simard JF
    Arthritis Rheum; 2006 Nov; 54(11):3378-80. PubMed ID: 17075813
    [No Abstract]   [Full Text] [Related]  

  • 40. Understanding the Precision in "Precision Medicine".
    Chabner BA
    Oncologist; 2016 Sep; 21(9):1029-30. PubMed ID: 27566249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.